Table 3.
The Top miRNA-Regulated Genes Targeting miRNAs That Were Identified as Significantly Dysregulated in the Exacerbating and Stable State COPD Cohorts, as Well as GOLD Classified Cohorts
| Patient Groups | Gene | miRNAs Targeting this Gene | Total # of Target Sites Identified in Target Gene | Range of Strength Scores (Min to Max) |
|---|---|---|---|---|
| Exacerbating vs stable state | Genes regulated by significantly under-expressed miRNA | |||
| HCN3 | hsa-miR-34a-5p | 4 | −0.359 to −0.182 | |
| NAV1 | hsa-miR-34a-5p | 4 | −0.25–0.041 | |
| NDST1 | hsa-miR-34a-5p | 3 | −0.035–0.038 | |
| SCN2B | hsa-miR-34a-5p | 3 | −0.21 to −0.059 | |
| ANKRD52 | hsa-miR-34a-5p | 2 | −0.12 to −0.029 | |
| Genes regulated by significantly over-expressed miRNAs | ||||
| AFF1 | hsa-miR-92b-3p | 5 | −0.3665 to −0.286 | |
| hsa-miR-374a-5p | ||||
| FBXW7 | hsa-miR-223-3p | 5 | −0.547 to −0.197 | |
| hsa-miR-92b-3p | ||||
| MEF2D | hsa-miR-374a-5p | 4 | −0.391 to −0.112 | |
| hsa-miR-92b-3p | ||||
| hsa-miR-223-3p | ||||
| AFF4 | hsa-miR-92b-3p | 4 | −0.275 to −0.032 | |
| hsa-miR-374a-5p | ||||
| HLF | hsa-miR-223-3p | 4 | −0.183 to −0.0652 | |
| hsa-miR-374a-5p | ||||
| GOLD Severe/ very severe vs GOLD Moderate | Genes regulated by significantly over-expressed miRNA | |||
| AFF1 | hsa-miR-374b-5p | 4 | −0.337 to −0.318 | |
| ACVR2B | hsa-miR-374b-5p | 3 | −0.603 to −0.232 | |
| PCDH10 | hsa-miR-374b-5p | 3 | −0.304 to −0.146 | |